Progress in Shigella vaccine development

被引：0

作者：

Kotloff, KL ^{[1
]}

机构：

[1] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA

来源：

VACCINES: PREVENTING DISEASE AND PROTECTING HEALTH | 2004年 / 596期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：130 / 139

页数：10

共 59 条

[1] Epidemiology of postshigellosis persistent diarrhea in young children [J].

Ahmed, F ;

Ansaruzzaman, M ;

Haque, E ;

Rao, MR ;

Clemens, JD .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (05) :525-530

[2] Attenuated Shigella flexneri 2a ΔguaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection [J].

Altboum, Z ;

Barry, EM ;

Losonsky, G ;

Galen, JE ;

Levine, MM .

INFECTION AND IMMUNITY, 2001, 69 (05) :3150-3158

[3]

[Anonymous], 1995, LANCET, V345, P339

[4] Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children [J].

Ashkenazi, S ;

Passwell, JH ;

Harlev, E ;

Miron, D ;

Dagan, R ;

Farzan, N ;

Ramon, R ;

Majadly, F ;

Bryla, DA ;

Karpas, AB ;

Robbins, JB ;

Schneerson, R .

JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (06) :1565-1568

[5] Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains [J].

Barry, EM ;

Altboum, Z ;

Losonsky, G ;

Levine, MM .

VACCINE, 2003, 21 (5-6) :333-340

[6] IDENTIFICATION OF ICSA, A PLASMID LOCUS OF SHIGELLA-FLEXNERI THAT GOVERNS BACTERIAL INTRA-CELLULAR AND INTERCELLULAR SPREAD THROUGH INTERACTION WITH F-ACTIN [J].

BERNARDINI, ML ;

MOUNIER, J ;

DHAUTEVILLE, H ;

COQUISRONDON, M ;

SANSONETTI, PJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) :3867-3871

[7]

Bingrui W, 1984, Arch Roum Pathol Exp Microbiol, V43, P285

[8] CHRONIC DIARRHEA AMONG ADULTS IN KIGALI, RWANDA - ASSOCIATION WITH BACTERIAL ENTEROPATHOGENS, RECTOCOLONIC INFLAMMATION, AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].

CLERINX, J ;

BOGAERTS, J ;

TAELMAN, H ;

HABYARIMANA, JB ;

NYIRABAREJA, A ;

NGENDAHAYO, P ;

VANDEPERRE, P .

CLINICAL INFECTIOUS DISEASES, 1995, 21 (05) :1282-1284

[9] PROSPECTIVE-STUDY OF THE ASSOCIATION BETWEEN SERUM ANTIBODIES TO LIPOPOLYSACCHARIDE O-ANTIGEN AND THE ATTACK RATE OF SHIGELLOSIS [J].

COHEN, D ;

GREEN, MS ;

BLOCK, C ;

SLEPON, R ;

OFEK, I .

JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (02) :386-389

[10] Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults [J].

Cohen, D ;

Ashkenazi, S ;

Green, MS ;

Gdalevich, M ;

Robin, G ;

Slepon, R ;

Yavzori, M ;

Orr, N ;

Block, C ;

Ashkenazi, I ;

Shemer, J ;

Taylor, DN ;

Hale, TL ;

Sadoff, JC ;

Pavliakova, D ;

Schneerson, R ;

Robbins, JB .

LANCET, 1997, 349 (9046) :155-159

← 1 2 3 4 5 6 →